Nevertheless, findings from published preclinical and clinical studies indicated that SSRIs are more beneficial compared to other antidepressant types on insulin sensitivity and glucose homeostasis in T2D patients with depression. This evidence concerns the gene INS and type 2 diabetes mellitus.